Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Drug Benefit Could Use Medicaid Price As Ceiling - Schondelmeyer

Executive Summary

Congress should consider using Medicaid prices as a ceiling for a federal Medicare drug benefit program, University of Minnesota PRIME Institute Director Stephen Schondelmeyer, PhD, suggested during a June 13 House Ways & Means Committee hearing.

You may also be interested in...



PBMs Could Reduce Rx Spending By 25% Under GOP Medicare Plan - CBO

The Congressional Budget Office estimates that pharmacy benefit management companies will generate a 25% reduction in retail drug costs under the House Medicare drug benefit bill.

PBMs Could Reduce Rx Spending By 25% Under GOP Medicare Plan - CBO

The Congressional Budget Office estimates that pharmacy benefit management companies will generate a 25% reduction in retail drug costs under the House Medicare drug benefit bill.

Drug Prices Not Responsible For Premium Hikes - HIAA, PhRMA Studies

Only a small part of recent increases in health insurance premiums can be attributed to the cost of prescription drugs, according to two reports released the week of April 10 by the pharmaceutical and health insurance industries.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036205

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel